Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?

scientific article published on 01 October 2011

Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3899/JRHEUM.110170
P698PubMed publication ID21965707

P2093author name stringDaniel Wendling
Emmanuelle Dernis
Clément Prati
Bernard Delbosc
Eric Frisch
P433issue10
P407language of work or nameEnglishQ1860
P921main subjecttocilizumabQ425154
eye diseaseQ3041498
P304page(s)2284
P577publication date2011-10-01
P1433published inThe Journal of RheumatologyQ7743623
P1476titleOnset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?
P478volume38

Reverse relations

cites work (P2860)
Q37632096A review and update on orphan drugs for the treatment of noninfectious uveitis
Q38559007Acute Anterior Uveitis and Spondyloarthritis: More Than Meets the Eye.
Q42147058Anti-interleukin-6 receptor antibody therapy-induced retinopathy in a patient with rheumatoid arthritis
Q38169978Ocular inflammatory diseases associated with rheumatoid arthritis.
Q34274075Pharmacotherapy for uveitis: current management and emerging therapy
Q37600483Update on the use of systemic biologic agents in the treatment of noninfectious uveitis
Q38021939Uveitis in seronegative arthritis
Q52852545[Treatment of posterior noninfectious uveitis : Current situation and future developments].

Search more.